Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
LISATA THERAPEUTICS, INC. (LSTA)
Standardized SEC financial data for LISATA THERAPEUTICS, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000320017 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
-83.0%
Return on equity
-113.6%
Free cash flow
-$16.0M
Debt / equity
0.00×
Current ratio
5.76×
EPS (diluted)
$-1.91
Ratios for fiscal year 2025, standardized from SEC filings.